Compare Humana Inc (HUM) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs PepsiCo, Inc. — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while PepsiCo, Inc. trades at $128.3 (market cap $168.88B). The key difference: PepsiCo, Inc. is far larger — about 3.5× Humana Inc's market cap, and PepsiCo, Inc. pays the higher dividend (4.78%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and PepsiCo, Inc. for 107 Days on average.
| HUM | PEP | |
|---|---|---|
Market Cap | $47.61B | $168.88B |
Volume | 1,827,332 | 13,263,972 |
Sector | Health | Consumer Staples |
52-Week High | $409.85 | $170.44 |
52-Week Low | $163.67 | $123.64 |
Typical Hold Time | 53 Days | 107 Days |
Enterprise Value | $54.97B | $211.38B |
Dividend Yield | 0.89% | 4.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
PepsiCo (PEP) trades at $128.88, up 2.52% today, with strong earnings momentum as it has beaten EPS estimates for four consecutive quarters. The stock shows bearish technical signals from moving averages but bullish oscillators, trading near support at $123. Fundamentally, PEP maintains solid profitability with 10.78% net margin and 51.59% ROE, though revenue growth remains modest at 2.2% in 2025. Recent news highlights price adjustments on snack products to address consumer pushback on high prices.
PEP offers value with a 16.22 P/E below industry averages and a 12.7% upside to the $145.25 consensus target, supported by 30% analyst buy ratings. However, risks include competitive pressure, margin compression from pricing actions, and technical weakness. The company's consistent dividend and earnings beats provide stability, but investors should monitor North American sales recovery and inflation impacts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
